logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Ana Ruiz-Garcı́a

gilead sciences, inc, foster city, usa
H指数:24
被引数:2,585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib
CANCER
IF5.1
2014-02-05134
OAAI
Reckamp, Karen L.; Giaccone, Giuseppe; Camidge, D. Ross; Gadgeel, Shirish M.; Khuri, Fadlo R.; Engelman, Jeff A.; Koczywas, Marianna; Rajan, Arun; Campbell, Alicyn K.; Gernhardt, Diana; Ruiz-Garcia, Ana; Letrent, Stephen; Liang, Jane; Taylor, Ian; O'Connell, Joseph P.; Jaenne, Pasi A.
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1,-2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors

达克替尼 (PF-00299804) 的I期和药代动力学研究，一种口服不可逆的人表皮生长因子受体-1，-2和-4酪氨酸激酶的小分子抑制剂，在日本晚期实体瘤患者中

INVESTIGATIONAL NEW DRUGS
IF2.7
2012-01-1761
OAAI
Takahashi, Toshiaki; Boku, Narikazu; Murakami, Haruyasu; Naito, Tateaki; Tsuya, Asuka; Nakamura, Yukiko; Ono, Akira; Machida, Nozomu; Yamazaki, Kentaro; Watanabe, Junichiro; Ruiz-Garcia, Ana; Imai, Keiji; Ohki, Emiko; Yamamoto, Nobuyuki

研究方向

暂未获取到该数据
J
Joseph Chen
H 指数:16论文数:80被引数:2,028
M
M. Naveed Shaik
H 指数:21论文数:77被引数:3,036
L
Luke Fostvedt
H 指数:8论文数:28被引数:364
M
Marival Bermejo
H 指数:37论文数:204被引数:6,011
J
Jennifer Hibma
H 指数:10论文数:40被引数:297
A
Andrew J. Wagner
H 指数:63论文数:525被引数:1.4万
N
Narikazu Boku
H 指数:75论文数:815被引数:2.9万
G
Giovanni Martinelli
H 指数:112论文数:2,328被引数:6.0万
D
D. Ross Camidge
H 指数:110论文数:999被引数:6.3万
J
Joanna C. Masters
H 指数:10论文数:48被引数:547